Investment company Massachusetts Institute of Technology (Current Portfolio) buys Zoom Video Communications Inc, Dada Nexus, Adverum Biotechnologies Inc, Ocular Therapeutix Inc, Ribbon Communications Inc, sells Salesforce.com Inc, CRISPR Therapeutics AG, IVERIC bio Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Massachusetts Institute of Technology. As of 2020Q4, Massachusetts Institute of Technology owns 9 stocks with a total value of $89 million. These are the details of the buys and sells.

For the details of Massachusetts Institute of Technology's stock buys and sells,
go to www.gurufocus.com/guru/massachusetts+institute+of+technology/current-portfolio/portfolio

These are the top 5 holdings of Massachusetts Institute of Technology

  1. Boston Omaha Corp (BOMN) - 2,070,328 shares, 64.14% of the total portfolio.
  2. Zoom Video Communications Inc (ZM) - 71,339 shares, 26.96% of the total portfolio. New Position
  3. Dada Nexus Ltd (DADA) - 86,579 shares, 3.54% of the total portfolio. New Position
  4. Adverum Biotechnologies Inc (ADVM) - 134,154 shares, 1.63% of the total portfolio. New Position
  5. Ocular Therapeutix Inc (OCUL) - 50,396 shares, 1.17% of the total portfolio. New Position

New Purchase: Zoom Video Communications Inc (ZM)

Massachusetts Institute of Technology initiated holding in Zoom Video Communications Inc. The purchase prices were between $337.32 and $568.34, with an estimated average price of $445.24. The stock is now traded at around $419.590000. The impact to a portfolio due to this purchase was 26.96%. The holding were 71,339 shares as of 2020-12-31.

New Purchase: Dada Nexus Ltd (DADA)

Massachusetts Institute of Technology initiated holding in Dada Nexus Ltd. The purchase prices were between $25.09 and $57.95, with an estimated average price of $37.29. The stock is now traded at around $46.440000. The impact to a portfolio due to this purchase was 3.54%. The holding were 86,579 shares as of 2020-12-31.

New Purchase: Adverum Biotechnologies Inc (ADVM)

Massachusetts Institute of Technology initiated holding in Adverum Biotechnologies Inc. The purchase prices were between $9.84 and $14.26, with an estimated average price of $12.4. The stock is now traded at around $14.010000. The impact to a portfolio due to this purchase was 1.63%. The holding were 134,154 shares as of 2020-12-31.

New Purchase: Ocular Therapeutix Inc (OCUL)

Massachusetts Institute of Technology initiated holding in Ocular Therapeutix Inc. The purchase prices were between $8.04 and $22.95, with an estimated average price of $14.96. The stock is now traded at around $19.760000. The impact to a portfolio due to this purchase was 1.17%. The holding were 50,396 shares as of 2020-12-31.

New Purchase: Ribbon Communications Inc (RBBN)

Massachusetts Institute of Technology initiated holding in Ribbon Communications Inc. The purchase prices were between $3.77 and $7.36, with an estimated average price of $5.3. The stock is now traded at around $8.860000. The impact to a portfolio due to this purchase was 1.03%. The holding were 139,568 shares as of 2020-12-31.

New Purchase: Burning Rock Biotech Ltd (BNR)

Massachusetts Institute of Technology initiated holding in Burning Rock Biotech Ltd. The purchase prices were between $22.55 and $30.87, with an estimated average price of $26.88. The stock is now traded at around $30.950000. The impact to a portfolio due to this purchase was 0.39%. The holding were 15,100 shares as of 2020-12-31.

Added: Apple Inc (AAPL)

Massachusetts Institute of Technology added to a holding in Apple Inc by 23.00%. The purchase prices were between $108.77 and $136.69, with an estimated average price of $120.34. The stock is now traded at around $136.760000. The impact to a portfolio due to this purchase was 0.1%. The holding were 3,701 shares as of 2020-12-31.

Sold Out: Salesforce.com Inc (CRM)

Massachusetts Institute of Technology sold out a holding in Salesforce.com Inc. The sale prices were between $220.15 and $267.07, with an estimated average price of $243.02.

Sold Out: CRISPR Therapeutics AG (CRSP)

Massachusetts Institute of Technology sold out a holding in CRISPR Therapeutics AG. The sale prices were between $79.67 and $173.23, with an estimated average price of $118.75.

Sold Out: IVERIC bio Inc (ISEE)

Massachusetts Institute of Technology sold out a holding in IVERIC bio Inc. The sale prices were between $5.65 and $7.66, with an estimated average price of $6.41.

Here is the complete portfolio of Massachusetts Institute of Technology. Also check out:

1. Massachusetts Institute of Technology's Undervalued Stocks
2. Massachusetts Institute of Technology's Top Growth Companies, and
3. Massachusetts Institute of Technology's High Yield stocks
4. Stocks that Massachusetts Institute of Technology keeps buying



Source link